SCHEMBL10076067

SCHEMBL10076067

Clc1nc(-c2ccccc2)cc(-c2ccc(-c3ccc(-c4cc(-c5ccccc5)nc(I)n4)cc3)cc2)n1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.74
KMT2A Q03164 9/20 0.74
ALDH1A1 P00352 5/20 0.74
HPGD P15428 5/20 0.74
L3MBTL1 Q9Y468 3/20 0.74
SMN1; SMN2 Q16637 2/20 0.74
MAPT P10636 5/20 0.66
KDM4E B2RXH2 4/20 0.66
TDP1 Q9NUW8 2/20 0.66
ADORA2A P29274 1/20 0.47
ADORA1 P30542 1/20 0.47
CTRC Q99895 1/20 0.46
NTSR1 P30989 1/20 0.46
HSP90AA1 P07900 1/20 0.44
HSP90AB1 P08238 1/20 0.44
AGTR1 P30556 1/20 0.43
TSHR P16473 1/20 0.43
ATM Q13315 1/20 0.43
CYP1A1 P04798 1/20 0.42
CYP1B1 Q16678 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30939448 0.90 MEN1 (0.91) MEN1KMT2AALDH1A1HPGDL3MBTL1
SCHEMBL13728744 0.90 MEN1 (0.91) MEN1KMT2AALDH1A1HPGDL3MBTL1
SCHEMBL16161050 0.90 MEN1 (0.91) MEN1KMT2AALDH1A1HPGDL3MBTL1
SCHEMBL19417179 0.90 MEN1 (0.56) MEN1KMT2AALDH1A1HPGDL3MBTL1
SCHEMBL10051514 0.90 MEN1 (0.91) MEN1KMT2AALDH1A1HPGDL3MBTL1
SCHEMBL24212278 0.90 MEN1 (0.91) MEN1KMT2AALDH1A1HPGDL3MBTL1
SCHEMBL25323 0.86 MEN1 (0.60) MEN1KMT2AALDH1A1HPGDL3MBTL1
SCHEMBL782567 0.86 MEN1 (1.00) MEN1KMT2AALDH1A1HPGDL3MBTL1
SCHEMBL5582376 0.85 MEN1 (0.80) MEN1KMT2AALDH1A1HPGDL3MBTL1
SCHEMBL15458659 0.85 MEN1 (0.80) MEN1KMT2AALDH1A1HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120104941-A1 COMPOUND FOR AN ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120104941-A1 COMPOUND FOR AN ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME PPOX, TYR, VDAC3 MEN1 3545/4885KMT2A 746/4885ALDH1A1 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.